Barclays »

Abcellera Biologics shares owned by Barclays

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $58k 22k 2.60
2024-06-30 $62k 21k 2.98
2024-03-31 $780k 172k 4.53
2023-12-31 $689k 121k 5.71
2023-09-30 $97k 21k 4.63
2023-06-30 $3.4M 526k 6.44
2023-03-31 $3.9M 521k 7.54
2022-12-31 $3.2M 317k 10.12
2022-09-30 $2.3M 236k 9.89
2022-06-30 $2.6M 241k 10.64
2022-03-31 $2.5M 248k 10.00